2025-05-15-Jefferies-爱尔康公司(ALC)_第一季度业绩未达预期;美国固定汇率增长放缓;展望下半年增长;重申买入评级及目标价115美元_10页_526kb
报告摘要
Alcon Inc. (ALC) Equity Research Summary
Rating: Buy
Price Target: $115
1Q25 Performance:
- Q1 revenue missed expectations by $60 MM (2.4%) and EPS by $0.02 (2.7%).
- US market remained slow, and legacy contact lens (CL) sales declined due to reduced promotion.
- Surgical and Vision Care segments partially missed targets due to competitive pressures and pricing moderation.
2025 Financial Guidance:
- Revenue growth adjusted to 6-7% (previously 6-8%), while market growth is now expected at 4% (down from 4-5%).
- EPS revised to $3.05-$3.15, reflecting broaderened Guidance Dilution (BD&L).
- Strong Q2-Q4 growth anticipated, driven by new product launches like Unity VCS and PanOptix Pro, which aim to boost Implantables revenue.
Product Developments & Catalysts:
graph LR
NewProducts[Unity VCS, PanOptix Pro] --> Catalysts[Eyesight gains, AR-15512 NDA mid-24]
- Contact Lens product lines (e.g., PRECISION1, P7) gaining traction, supported by trade-up effects and pricing.
- Implantables growth expected to improve in H2, with tariffs ($80 MM COGS impact) offset through operational and FX actions.
Valuation & Risk Assessment:
- Target Price: $115 (31x 2026E EPS), +32% upside.
- Base Case: 6.7% 3-year revenue CAGR (2024-2027).
- Upside Scenario: 7.7% CAGR driven by strong China VBP uptake in Surgical equipment.
- Downside Risk: Slower CL uptake and competitive hardware in Implantables, tariffs, pricing pressures, and economic slowdown.
Financial Highlights:
- Surgical segment: Equipment expected to grow due to Unity; CLs benefited from pricing, but Implantables lagged.
- Margin pressure: Reduced gross margin (adjusted) to 63.7%, OpEx stabilized.
- Capital expenditures to support China VBP initiatives and green energy transitions.
Sustainability & ESG:
- Material issues include product lifecycle designs, quality compliance, and employee engagement metrics.
- Targets focus on waste reduction, renewable energy, and green energy investments.
Recommendation:
- Buy rating reflects strong growth trajectory and new product cycles.
- H2 performance heavily dependent on Unity and PanOptix launches.
- Monitor tariffs, competitive trials, and pricing dynamics for long-term margin sustainability.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载